Key result
Concomitant surgical ablation during aortic surgery does not increase 30-day mortality or stroke risk.
Why the study?
Limited data are available on the treatment of atrial fibrillation during ascending aortic aneurysm and aortic valve surgery.
Does concomitant atrial fibrillation ablation improve outcomes in patients undergoing elective ascending aortic aneurysm and aortic valve surgery?
Cohort (n=236)
Does concomitant atrial fibrillation ablation improve outcomes in patients undergoing elective ascending aortic aneurysm and aortic valve surgery?
Concomitant surgical ablation of atrial fibrillation during ascending aortic aneurysm and aortic valve surgery is safe and yields long-term survival and stroke outcomes comparable to patients without preoperative atrial fibrillation.
Supports safety of concomitant ablation in aortic surgery; leaves open need for RCTs to confirm outcome benefits.
Objective: Limited data are available on treatment of atrial fibrillation during ascending aortic aneurysm and aortic valve surgery. Ablation at the time of isolated aortic valve surgery has a Society of Thoracic Surgeons Class I indication. We sought to determine early and late outcomes of concomitant atrial fibrillation surgery at the time of ascending aortic aneurysm + aortic valve surgery. Methods: From July 2008 to June 2023, patients undergoing elective ascending aortic aneurysm + aortic valve surgery ± atrial fibrillation surgery were compared. Clinical follow-up was conducted annually (median 5.6 [3.1-9.2] years). Results: 236). Conclusions: For patients undergoing aneurysm surgery concomitantly with aortic valve surgery, surgical ablation was effective and did not increase 30-day mortality. Survival and stroke outcomes were similar to a matched reference group without preoperative atrial fibrillation. Ablation of atrial fibrillation should be considered at the time of aortic surgery.
No takes yet. Share an insight, caveat, or question.
Robinson et al. (2025) conducted a cohort in Atrial fibrillation during ascending aortic aneurysm and aortic valve surgery (n=236). Concomitant atrial fibrillation surgery (ablation) vs. Matched reference group without preoperative atrial fibrillation was evaluated on 30-day mortality, survival, and stroke. Concomitant surgical ablation during ascending aortic aneurysm and aortic valve surgery did not increase 30-day mortality and yielded survival and stroke outcomes similar to a matched reference group.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: